Lotus Eye Hospital & Institute Ltd (LOTUSEYE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 959118,
    "name": "Lotus Eye Hospit",
    "stock_name": "Lotus Eye Hospit",
    "full_name": "Lotus Eye Hospital & Institute Ltd",
    "name_url": "stocks-analysis/lotus-eye-hospit",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "115.75",
    "chg": -6,
    "chgp": "-4.93%",
    "dir": -1,
    "prev_price": "121.75",
    "mcapval": "259.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532998,
    "symbol": "LOTUSEYE",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE947I01017",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "20.79 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/lotus-eye-hospit-959118-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Lotus Eye Hospit Sees Revision in Market Assessment Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lotus-eye-hospit-upgraded-from-strong-sell-to-hold-by-marketsmojo-3744066",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/LotusEyeHospit_mojoScore_3744066.png",
        "date": "2025-12-03 11:08:04",
        "description": "Lotus Eye Hospit has experienced a revision in its market evaluation, reflecting a shift in analytical perspective driven by a combination of financial trends, valuation considerations, and technical factors. Despite challenges in profitability and valuation metrics, the stock’s recent performance relative to the broader market has drawn renewed attention."
      },
      {
        "title": "Why is Lotus Eye Hospit falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-lotus-eye-hospit-fallingrising-3709359",
        "imagepath": "",
        "date": "2025-11-17 23:36:10",
        "description": "As of 17-Nov, Lotus Eye Hospital & Institute Ltd is experiencing a decline in its stock price, currently at 106.50, reflecting a decrease of 4.45 points or 4.01%. The stock has been underperforming recently, having fallen consecutively for the last three days, resulting in a total decline of 11.95% during this period. Today, it opened with a loss of 4.87% and reached an intraday low of Rs 105.55. The stock's performance over the past week and month shows a significant downturn, with returns of -9.75% and -9.82%, respectively, while it has performed well year-to-date and over the past year, with increases of 54.73% and 63.85%. There is no information available regarding positive or negative factors that could be influencing the stock's recent movement.\n\nBroader Market Context: In comparison to the benchmark, the Sensex has gained 1.69% over the past week, while Lotus Eye Hospital's stock has seen a decline o..."
      },
      {
        "title": "Lotus Eye Hospital Stock Hits Lower Circuit Limit at Rs 109.17, Declines 5% Intraday",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lotus-eye-hospital-stock-hits-lower-circuit-limit-at-rs-10917-declines-5-intraday-3701820",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LotusEyeHospita_stocks_hitting_lower_circuit_3701820.png",
        "date": "2025-11-14 14:00:09",
        "description": "Lotus Eye Hospital & Institute Ltd experienced significant trading activity today, hitting its lower circuit limit and closing at Rs 112.50. The stock has underperformed its sector and faced a consecutive decline over the past two days. Increased delivery volume suggests rising investor participation despite recent challenges."
      },
      {
        "title": "Lotus Eye Hospital Q2 FY26: Profitability Under Pressure Despite Stable Revenue",
        "link": "https://www.marketsmojo.com/news/result-analysis/lotus-eye-hospital-q2-fy26-profitability-under-pressure-despite-stable-revenue-3715102",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LotusEyeHospita_quaterlyResult_3715102.png",
        "date": "2025-11-14 09:39:15",
        "description": "Lotus Eye Hospital & Institute Ltd., a Coimbatore-based speciality eye care provider, reported a challenging quarter for Q2 FY26 (July-September 2025), with net profit declining to ₹0.12 crores from ₹0.54 crores in the previous quarter, marking a sharp 77.78% sequential contraction. On a year-over-year basis, net profit rose modestly by 20.00% from ₹0.10 crores in Q2 FY25. The company's stock, currently trading at ₹111.00, has declined 3.56% following the results announcement, reflecting investor concerns about deteriorating margins and operational efficiency."
      },
      {
        "title": "How has been the historical performance of Lotus Eye Hospit?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-lotus-eye-hospit-3699612",
        "imagepath": "",
        "date": "2025-11-13 23:43:50",
        "description": "Answer:\nThe historical performance of Lotus Eye Hospital shows a mixed trend over the years, with fluctuations in revenue and profit metrics.\n\nBreakdown:\nLotus Eye Hospital's net sales have shown a steady increase from INR 32.37 crore in March 2021 to INR 49.56 crore in March 2025, with a notable rise from INR 38.91 crore in March 2022. Total operating income has mirrored this trend, reaching INR 49.56 crore in March 2025. However, the total expenditure has also increased significantly, from INR 28.81 crore in March 2021 to INR 46.13 crore in March 2025, impacting operating profit, which fell from INR 7.58 crore in March 2023 to INR 3.43 crore in March 2025. Consequently, profit before tax decreased from INR 5.65 crore in March 2023 to INR 1.38 crore in March 2025, with profit after tax also declining from INR 4.08 crore to INR 0.74 crore during the same period. The company's total assets rose from INR 57.2..."
      },
      {
        "title": "Why is Lotus Eye Hospit falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-lotus-eye-hospit-fallingrising-3699373",
        "imagepath": "",
        "date": "2025-11-13 23:34:08",
        "description": "As of 13-Nov, Lotus Eye Hospital & Institute Ltd's stock price is currently at 115.00, reflecting a decline of 5.95 points or 4.92%. The stock has underperformed its sector by 4.69% today and opened with a loss of 4.88%. It reached an intraday low of Rs 115, indicating a significant drop. Additionally, the stock's delivery volume has decreased dramatically, falling by 84.55% compared to the 5-day average, suggesting a decline in investor participation. While the stock has shown strong performance year-to-date with a gain of 67.08% and a one-year increase of 79.66%, it has recently struggled, with a 1-week decline of 5.93% and a 1-month drop of 6.35%. There is no information available regarding positive or negative factors impacting the stock.\n\nBroader Market Context: In comparison to the benchmark Sensex, which has increased by 1.40% over the past week and 2.61% over the past month, Lotus Eye Hospital's rec..."
      },
      {
        "title": "How has been the historical performance of Lotus Eye Hospit?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-lotus-eye-hospit-3695626",
        "imagepath": "",
        "date": "2025-11-13 00:33:06",
        "description": "Answer:\nThe historical performance of Lotus Eye Hospital shows a mixed trend over the years, with fluctuations in revenue and profit metrics.\n\nBreakdown:\nLotus Eye Hospital's net sales have shown a steady increase from INR 32.37 crore in March 2021 to INR 49.56 crore in March 2025. Total operating income followed a similar trend, reaching INR 49.56 crore in March 2025, up from INR 38.91 crore in March 2022. However, total expenditure has also risen, from INR 28.81 crore in March 2021 to INR 46.13 crore in March 2025, impacting operating profit, which decreased from INR 7.58 crore in March 2023 to INR 3.43 crore in March 2025. Profit before tax similarly declined from INR 5.65 crore in March 2023 to INR 1.38 crore in March 2025, leading to a profit after tax of INR 0.74 crore in March 2025, down from INR 4.08 crore in March 2023. The company's total assets increased from INR 57.26 crore in March 2020 to INR ..."
      },
      {
        "title": "Why is Lotus Eye Hospit falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-lotus-eye-hospit-fallingrising-3677610",
        "imagepath": "",
        "date": "2025-11-06 23:36:41",
        "description": "As of 06-Nov, Lotus Eye Hospital & Institute Ltd is currently priced at 124.50, reflecting a decrease of 0.75, or 0.6%. The stock has been experiencing a decline, having lost 4.16% over the last two days. Despite this recent downturn, the stock has shown strong performance over longer periods, with a year-to-date increase of 80.88% and a five-year growth of 314.31%. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally positive trend prior to the recent falls. There is also a notable increase in investor participation, with delivery volume rising by 89.04% compared to the 5-day average, suggesting continued interest in the stock despite its short-term decline. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nIn the broader market context, the sto..."
      }
    ],
    "total": 125,
    "sid": "959118",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/lotus-eye-hospital-institute-959118"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for The Quarter Ended 31St December 2025",
      "datetime": "30-Jan-2026",
      "details": "Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve Consideration of financial results for the quarter ended 31.12.2025",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011",
      "datetime": "27-Jan-2026",
      "details": "The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sangeetha Sundaramoorthy",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "19-Jan-2026",
      "details": "Results of voting by postal ballot and scrutinizers report",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lotus Eye Hospital & Institute Ltd has declared <strong>5%</strong> dividend, ex-date: 18 Sep 23",
          "dt": "2023-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Lotus Eye Hospit Sees Revision in Market Assessment Amid Mixed Financial Signals

2025-12-03 11:08:04

Lotus Eye Hospit has experienced a revision in its market evaluation, reflecting a shift in analytical perspective driven by a combination of financial trends, valuation considerations, and technical factors. Despite challenges in profitability and valuation metrics, the stock’s recent performance relative to the broader market has drawn renewed attention.

Why is Lotus Eye Hospit falling/rising?

2025-11-17 23:36:10

As of 17-Nov, Lotus Eye Hospital & Institute Ltd is experiencing a decline in its stock price, currently at 106.50, reflecting a decrease of 4.45 points or 4.01%. The stock has been underperforming recently, having fallen consecutively for the last three days, resulting in a total decline of 11.95% during this period. Today, it opened with a loss of 4.87% and reached an intraday low of Rs 105.55. The stock's performance over the past week and month shows a significant downturn, with returns of -9.75% and -9.82%, respectively, while it has performed well year-to-date and over the past year, with increases of 54.73% and 63.85%. There is no information available regarding positive or negative factors that could be influencing the stock's recent movement. Broader Market Context: In comparison to the benchmark, the Sensex has gained 1.69% over the past week, while Lotus Eye Hospital's stock has seen a decline o...

Lotus Eye Hospital Stock Hits Lower Circuit Limit at Rs 109.17, Declines 5% Intraday

2025-11-14 14:00:09

Lotus Eye Hospital & Institute Ltd experienced significant trading activity today, hitting its lower circuit limit and closing at Rs 112.50. The stock has underperformed its sector and faced a consecutive decline over the past two days. Increased delivery volume suggests rising investor participation despite recent challenges.

Lotus Eye Hospital Q2 FY26: Profitability Under Pressure Despite Stable Revenue

2025-11-14 09:39:15

Lotus Eye Hospital & Institute Ltd., a Coimbatore-based speciality eye care provider, reported a challenging quarter for Q2 FY26 (July-September 2025), with net profit declining to ₹0.12 crores from ₹0.54 crores in the previous quarter, marking a sharp 77.78% sequential contraction. On a year-over-year basis, net profit rose modestly by 20.00% from ₹0.10 crores in Q2 FY25. The company's stock, currently trading at ₹111.00, has declined 3.56% following the results announcement, reflecting investor concerns about deteriorating margins and operational efficiency.

How has been the historical performance of Lotus Eye Hospit?

2025-11-13 23:43:50

Answer: The historical performance of Lotus Eye Hospital shows a mixed trend over the years, with fluctuations in revenue and profit metrics. Breakdown: Lotus Eye Hospital's net sales have shown a steady increase from INR 32.37 crore in March 2021 to INR 49.56 crore in March 2025, with a notable rise from INR 38.91 crore in March 2022. Total operating income has mirrored this trend, reaching INR 49.56 crore in March 2025. However, the total expenditure has also increased significantly, from INR 28.81 crore in March 2021 to INR 46.13 crore in March 2025, impacting operating profit, which fell from INR 7.58 crore in March 2023 to INR 3.43 crore in March 2025. Consequently, profit before tax decreased from INR 5.65 crore in March 2023 to INR 1.38 crore in March 2025, with profit after tax also declining from INR 4.08 crore to INR 0.74 crore during the same period. The company's total assets rose from INR 57.2...

Why is Lotus Eye Hospit falling/rising?

2025-11-13 23:34:08

As of 13-Nov, Lotus Eye Hospital & Institute Ltd's stock price is currently at 115.00, reflecting a decline of 5.95 points or 4.92%. The stock has underperformed its sector by 4.69% today and opened with a loss of 4.88%. It reached an intraday low of Rs 115, indicating a significant drop. Additionally, the stock's delivery volume has decreased dramatically, falling by 84.55% compared to the 5-day average, suggesting a decline in investor participation. While the stock has shown strong performance year-to-date with a gain of 67.08% and a one-year increase of 79.66%, it has recently struggled, with a 1-week decline of 5.93% and a 1-month drop of 6.35%. There is no information available regarding positive or negative factors impacting the stock. Broader Market Context: In comparison to the benchmark Sensex, which has increased by 1.40% over the past week and 2.61% over the past month, Lotus Eye Hospital's rec...

How has been the historical performance of Lotus Eye Hospit?

2025-11-13 00:33:06

Answer: The historical performance of Lotus Eye Hospital shows a mixed trend over the years, with fluctuations in revenue and profit metrics. Breakdown: Lotus Eye Hospital's net sales have shown a steady increase from INR 32.37 crore in March 2021 to INR 49.56 crore in March 2025. Total operating income followed a similar trend, reaching INR 49.56 crore in March 2025, up from INR 38.91 crore in March 2022. However, total expenditure has also risen, from INR 28.81 crore in March 2021 to INR 46.13 crore in March 2025, impacting operating profit, which decreased from INR 7.58 crore in March 2023 to INR 3.43 crore in March 2025. Profit before tax similarly declined from INR 5.65 crore in March 2023 to INR 1.38 crore in March 2025, leading to a profit after tax of INR 0.74 crore in March 2025, down from INR 4.08 crore in March 2023. The company's total assets increased from INR 57.26 crore in March 2020 to INR ...

Why is Lotus Eye Hospit falling/rising?

2025-11-06 23:36:41

As of 06-Nov, Lotus Eye Hospital & Institute Ltd is currently priced at 124.50, reflecting a decrease of 0.75, or 0.6%. The stock has been experiencing a decline, having lost 4.16% over the last two days. Despite this recent downturn, the stock has shown strong performance over longer periods, with a year-to-date increase of 80.88% and a five-year growth of 314.31%. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally positive trend prior to the recent falls. There is also a notable increase in investor participation, with delivery volume rising by 89.04% compared to the 5-day average, suggesting continued interest in the stock despite its short-term decline. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement. In the broader market context, the sto...

View All News